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ORIGINAL ARTICLE
Diabetes mellitus is a highly prevalent, costly con-
dition associated with substantial worldwide mor-
bidity and mortality. In Taiwan, the overall 5-year
incidences for men and women were 187.1 and
218.4 per 100,000 population, respectively.1 The
high incidence is accounted for by type 2 diabetes
(97%).2,3 There are about 1 million people with
diabetes, and health care costs for these diabetic
patients amount to 11.5% of the total healthcare
expenditure.4 Moreover, most diabetic patients
were found to lack the ability to control their dis-
ease appropriately, for example, nearly 30% of
diabetics were found to have an HbA1c level over
10%.3,4 Improving self-management, preventing
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Background/Purpose: The purpose of this study was to test the psychometric properties of the Perceived
Therapeutic Efficacy Scale (PTES) for type 2 diabetes with a Taiwanese sample. The mortality rate and
health care cost of diabetes have dramatically increased in Taiwan, with many people with diabetes lacking
the ability to control their disease appropriately. Addressing this problem requires enhancing self-efficacy
towards self-management. Thus, there is a particular need for research into developing a diabetes-specific
self-efficacy measurement instrument in Taiwan.
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Results: Significant criterion-related validity was demonstrated between the C-PTES and the Summary of
Diabetes Self-Care Activities scores (r = 0.32; p < 0.01). Convergent validity was confirmed as the C-PTES
converged well with the General Self-Efficacy Scale in measuring self-efficacy (r = 0.42; p < 0.01); construct
validity using factor analysis composed a single subscale. Internal consistency showed Cronbach’s α was
0.95 and the test–retest reliability (Pearson’s correction) was 0.79 (p < 0.01) and a Bland-Altman plot
showed that 97% of the subjects were within two standard deviations of the mean.
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complications and reducing health service uti-
lization for people with diabetes is an ongoing
challenge for Taiwanese health care providers.
Diabetes is a self-managed disease and people
with diabetes are responsible for decisions re-
garding food intake, foot care, exercise, eye care,
and adherence to a diabetes regimen to prevent
medical complications.5 Low levels of psychosocial
support and self-efficacy factors are considered
as barriers to diabetes management.6 Bolstering
patients’ confidence about their ability to success-
fully implement care is a critical step in promoting
active self-management.7 Research affirms that
people with higher diabetes self-efficacy follow
better care practices.6 Self-efficacy is one impor-
tant part of social cognitive theory and was defined
as “people’s belief in their capability to organize
and execute the course of action required where
dealing with prospective situations”.8 There are
two cognitive components in the theory: efficacy
expectations and outcome expectations.8 Bandura9
proposed that behavior is best predicted by con-
sidering both self-efficacy and outcome expec-
tations. It is important to involve both cognitive
components and incorporate self-efficacy theory
for the self-management of diabetes.
In Taiwan, facilitating personal self-efficacy of
an individuals’ ability to manage self-care regi-
mens is viewed as an effective solution for diabetes
management. However, no instruments measuring
self-efficacy towards management of diabetes have
been found and appropriately used to measure
the effectiveness of self-management. Most stud-
ies developing specific instruments to measure
self-efficacy just focus on measuring efficacy ex-
pectations (self-efficacy), and very few studies focus
on measuring outcome expectations. The Perceived
Therapeutic Efficacy Scale (PTES) was developed in
the USA by Dunbar-Jacob,10 and measures peo-
ple’s belief that a behavior will have the desired
effect (outcome expectations). In particular, it fo-
cuses on activities of people with type 2 diabetes
who are taking prescribed medication. The tool
consists of 10 items with responses rated on an
11-point scale ranging from “no confidence” (0
points) to “highest confidence” (10 points). This
tool has been found to have acceptable reliability
and validity in the USA and UK. Internal consis-
tency (Cronbach’s α, 0.94–0.96) and test–retest
reliability (0.64–0.80) are high.10,11 The aim of
this study was to translate the PTES into Chinese
and present the results of reliability and validity
testing of the PTES in a Taiwanese sample.
Methods
Design
This study was undertaken in two stages. Stage 1,
translation and development of the Chinese ver-
sion of the PTES (C-PTES), was undertaken in six
steps. First, two professional bilingual translators
independently translated the PTES from English
into Chinese. Second, a meeting of five experts
(two bilingual translators, two Chinese researchers
and a diabetes educator) agreed the translation was
accurate. Third, diabetes educators and patients
commented on the wording and meaning of the
instrument during a group discussion. Fourth, two
native English speaker translators with experience
in biomedical sciences and nursing but unaware
of the original English PTES performed a back-
translation of the Chinese PTES format into the
English language and then three experts (two na-
tive English speaking researchers, and a bilingual
Chinese researcher) compared the instrument with
the original to identify any linguistic inaccuracies.
Finally, the content validity was examined. These
processes aimed to ensure the equivalent mean-
ing of items in both languages. After that, stage
two established the psychometric properties of the
C-PTES by examining criterion, convergent and
construct validity, and by testing internal consis-
tency and stability.
Sample and data collection methods
The sample for stage two was recruited from a di-
abetes outpatient clinic in Taipei, Taiwan. It com-
prised 230 people with type 2 diabetes who were
aged 30 years or more and had an oral medica-
tion regime for diabetes. The sample size required
to conduct a factor analysis was determined using
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the recommended ratio of at least five participants
for each item.12 After advertising on a notice board
in the outpatient clinic, 245 patients with type 2
diabetes were asked to participate in the study. Of
these 245 patients, 15 did not complete the study.
There were seven withdrawals for non-specified
reasons, three patients did not meet the inclusion
criteria and five did not complete the question-
naire. Therefore, the data of 230 respondents was
analyzed. The mean age was 63.3 ± 12.5 years with
a diagnosis of diabetes on average for 8.6 ± 8.2
years. The sample consisted of 45% men. Thirty-
one percent had primary school education only,
and 54% were unemployed or retired. Two weeks
after the initial survey, a random sample of 30
participants (selected by using a random number
table) were asked to fill in the same questionnaire
when they visited a doctor in the same outpatient
setting. This retesting was conducted to test the
temporal stability of this instrument. The mean age
of this subgroup was 61.3 ± 12.4 years with 50%
men. The characteristics of the subgroup sample
were similar to those of the total sample.
Instruments
The Chinese version of the SDSCA (Summary of
Diabetes Self-Care Activities) scale13 was chosen
for testing criterion validity and assesses the his-
tory of self-care activities of people with diabetes.
The SDSCA is a self-reporting measure of the fre-
quency of performing diabetes self-care tasks such
as diet, exercise, medication taking, blood sugar
testing, and foot care over the preceding 7 days
(0–7 points). The tool consists of 12 items and
possible total scores range from 0 to 84 points.
The Chinese version of the SDSCA has demon-
strated acceptable reliability (0.55–0.64).13 It was
chosen for testing criterion validity. The Cronbach’s
α coefficient of the Chinese version of the SDSCA
in this study was 0.70.
The Chinese version of the General Self-Efficacy
(GSE) Scale14 was used to test for convergent va-
lidity. The GSE is a 10-item scale that was designed
to assess general and optimistic self-belief to cope
with a variety of difficult demands in life, and
measured the strength dimension of self-efficacy.
There is a 0–3 point Likert scale response format
for each item of the Chinese version of the GSE.
Scores are summed to give a total range from 0 to
30; higher scores represent greater self-efficacy.
The Chinese version GSE has a high internal con-
sistency (Cronbach’s α, 0.91–0.92).14,15 The in-
ternal consistency (Cronbach’s α) of the Chinese
version of the GSE in this study was 0.93. This
tool was used to test for convergent validity be-
cause the target scale (PTES) of this study mea-
sures people’s belief that a behavior will have the
desired effect (outcome expectations), especially
if it focuses on activities of people with type 2 dia-
betes who are taking prescribed medication. It is
expected participants who reported better C-PTES
scores would also report having better GSE scores.
Ethical considerations
Ethical approval was received from the Human
Research Ethics Committees of Queensland Uni-
versity of Technology, Pace University and National
Taipei College of Nursing. The researcher pro-
vided participants with an information sheet and
explained the details of the study to potential
participants prior to obtaining written informed
consent. If participants were unable to complete
the questionnaire alone, they were provided with
assistance from the data collector. If participants
became weary, the interview was ceased and re-
sumed at a later time. Anonymity and confiden-
tiality were assured and participants were informed
they could withdraw from the study at any time
without comment or penalty to their present or
further care.
Data analysis
Data were double-entered for verification using
SPSS statistical software (SPSS Inc., Chicago, IL,
USA). For the purpose of establishing criterion-
related validity, the Summary of Diabetes Self-Care
Activities (SDSCA) scale13 was used and Pearson’s
correlation examined criterion validity. Pearson’s
correlation coefficients were calculated between
the C-PTES and the Chinese version of the GSE14
to test the convergent validity of the scales. Fac-
tor analysis was used to determine the construct
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validity. Cronbach’s α coefficient was calculated
to test for internal consistency. Pearson’s corre-
lation coefficient and Bland-Altman plots with
95% limits of agreement (LOA) were performed
to evaluate stability through a test–retest of the
tool at a 2-week interval.
Results
Content validity
The average Content Validity Index (CVI) score
obtained by C-PTES was 0.83. Based on expert
panel comments, the wording of only four items
was modified. These included Item No. 2, (CVI =
0.82), Item No. 5 (CVI = 0.84), Item No. 9 (CVI =
0.78) and Item No. 10 (CVI = 0.78). After revision,
the meaning was more complete and easier for
people, especially the elderly, to understand. The
expert panel believed the modifications of the con-
tent and wording were necessary to ensure the
words reflected Taiwanese culture, and would be
easier for patients to understand.
Criterion validity
Result revealed that the Pearson’s correlation co-
efficient between C-PTES and SDSCA was r = 0.32
(p < 0.01), demonstrating that outcome expec-
tations are moderately correlated with self-care
performances.
Convergent validity
Pearson’s correlation coefficient between scores on
the C-PTES and the Chinese version GSE revealed
a moderately positive association (r=0.42; p<0.01).
Construct validity
Data were analyzed by means of principal-axis fac-
toring with direct oblimin. The following criteria
were used to obtain the best fitting structure and
an appropriate number of factors: (1) Eigenvalues
greater than 1.0; (2) Cattell’s scree test; (3) the per-
centage of total variance explained by each factor;
and (4) factor loading cut-off of 0.40. Bartlett’s
test of sphericity for the C-PTES was significant
(χ2 =2183.13; p<0.01) and the Kaiser-Meyer-Olkin
measure of sampling adequacy was found to be
acceptable at 0.93. The principal-axis factoring
for the C-PTES revealed only one factor with an
Eigenvalue > 1, explaining 71% of the total sample
variance. An examination of the scree plot and
the Eigenvalues suggested that a one-factor solu-
tion (10 items all loaded above 0.40) accounting
for 71% of the variance was acceptable.
Internal consistency
The C-PTES showed high internal consistency in
this study (Cronbach’s α 0.95). The item-to-total
correlations ranged from 0.75 to 0.86. All of the
10 items had high item–total correlation values.
We have translated all the items from the origi-
nal instrument, and for consistency, all the items
should be included.
Stability
The test–retest was calculated using Pearson’s cor-
relation to determine the strength of the relation-
ship between responses (n=30) to the C-PTES over
time, with 2 weeks between administrations. The
test–retest reliability resulted in a coefficient of
0.79 (ranging from 0.73 to 0.84; p < 0.01) for the
C-PTES. Test–retest reliability for the C-PTES was
also examined by means of a Bland-Altman plot
with 95% LOA to offer information regarding
agreement and detection of systematic bias in re-
sponse from one time to another. The mean dif-
ference of the total C-PTES score was 3.90 and the
95% confidence interval for the mean difference
ranged from −14.37 to + 22.17. Only one subject
was outside the limits of agreement and 97% (29/
30) of the subjects were within two standard de-
viations of the mean. Ninety-five percent of those
differences, as expected, fell within ± 2 SDs of the
mean difference between the test–retest scores.
The C-PTES was deemed to be a stable over the
2-week testing period.
Discussion
Adapting an existing instrument for cross-cultural
use not only requires language translation; cultural
and environmental characteristics need to be taken
into account also. Some items on the C-PTES scale
changed to provide a more culturally appropriate
wording during the content validity process and
the total average score was an acceptable 0.83 of
CVI. This indicates that the C-PTES had content
validity.
The PTES measures participants’ outcome ex-
pectation and the extent to which the individual
believes their treatment will lead to personally
desirable outcomes.10 The results of Pearson’s cor-
relation coefficients (r = 0.32; p < 0.01) showed
that C-PTES correlated with self-care activities.
These results were similar to Williams and Bond’s
study16 which showed that outcome expectancies
positively correlated with self-care activities.
The C-PTES and the Chinese version of the GSE
total score revealed positive associations (r = 0.42;
p < 0.01). We tested the relationship between the
C-PTES and the Chinese version of GSE to pro-
vide evidence of the instrument’s ability to mea-
sure underlying self-efficacy. The results provided
evidence that C-PTES does measure the self-efficacy
concept. This is the first time that the PTES has been
tested for convergent validity and the results pro-
vide evidence that the C-PTES does measure self-
efficacy. However, this study did not collect data,
such as disease severity, to analyze the discriminant
validity. Further studies need to consider testing
the discriminant validity.
The results of the factor analysis revealed one
factor, rotated in the initial solution, which had an
Eigenvalue > 1.0. This result was consistent with
previous analysis of the English version of the
PTES in the UK, which also generated only one
single factor related to medication.11
The internal consistency of the analysis resulted
in an alpha of 0.95 for the C-PTES. A similar result
was found in a study in a UK population where
the Cronbach’s α for the English version of the
PTES was reported as 0.94 (n = 121).11 Although
the alpha is high and could suggest items over-
lap, we believe that in some situations, a higher
coefficient may be required as the higher the co-
efficient, the more stable the measure.17 The item-
to-total correlations ranged from 0.75 to 0.86 and
were assessed to contribute to the internal con-
sistency. Nunnally and Bernstein18 noted that items
with high item-total correlation values have more
variance and add more to the reliability of a test
than items with low correlation values. Therefore,
items with low item–total correlation should be
considered for deletion from the scale. To reach the
desired reliability, items were deleted one-at-a-
time from the C-PTES. However, item deletion did
not effectively change the reliability of the C-PTES.
Moreover, the content validity for the overall CVI
was appropriate. We have translated all the items
from the original instrument and, for consistency,
all the items should be included. Thus, in the end,
no items were deleted in terms of item analysis.
The results of the test–retest indicated good
consistency over time. A similar good stability 
result was found in a UK population.11 Moreover,
to offer information regarding agreement and
detection of systematic bias in response from one
time to another, a Bland-Altman plot19 was used
to graphically display the variability involved in
this study. The results of the mean difference were
greater than 0, indicating that there may be bias
in the data. This may be attributed to participant’s
previous knowledge of the C-PTES scale. The level
of agreement (2 SDs of the difference between
the test–retest measurements) between individual
responses over time is strong. Thus, one can con-
clude that the C-PTES is a stable instrument. How-
ever, as this is a newly developed instrument, the
C-PTES needs further replication studies that will
further contribute to evidence of its reliability and
validity.
The results of this study support the psychome-
tric properties of the C-PTES in providing a mea-
sure of self-efficacy specific to patients with type 
2 diabetes. The 10-item C-PTES (Table) is rela-
tively short and is easy to administer to Taiwanese
patients with diabetes. It generally requires only
10 minutes for completion, though about 12 min-
utes for the elderly. For developing professional
knowledge, in regard to self-efficacy in diabetes
care in Taiwan, the establishment of psychomet-
rically sound assessment tools for clinical use is
very important. The above evidence of reliability
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and validity strengthens confidence in using the
C-PTES. Validation of a measurement tool is an
ongoing process. The C-PTES thus needs future
studies to strengthen the psychometric properties.
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